—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
JAMA Oncology《肿瘤学纪要》
- 月刊
  • JAMA Oncology《肿瘤学纪要》
  • 复合影响因子:0
  • 维普目次
  •  
  投稿方式:官网投稿 https://jamanetwork.com/journals/jamaoncology
  • 栏目频次
  • 一作占比
  • 单位占比
  • 热词
暂无栏目信息.
暂无一作信息.
暂无关键词信息.
  • 更多

    期刊简介

  • JAMA Oncology《肿瘤学纪要》(月刊). JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

  • 基本信息

  • 期刊名称:JAMA Oncology《肿瘤学纪要》
  • 主管单位:《肿瘤学纪要》
  • 主办单位:JAMA ONCOL
  • 国内刊号:
  • 国际刊号:ISSN2374-2437;EISSN2374-2445
  • 出刊日期:http://www.ama-assn.org
    期刊定价:0
  • 邮发代码:1区
  • 所在省区:美国
    邮政编码:
  • 联系地址:330 N WABASH AVE, STE 39300, CHICAGO, USA, IL, 60611-5885

  • 投稿信息

  • 学科分类:
    版面费用:1.70%
  • 字数要求:0
    查重要求:-
  • 复合因子:0
    综合因子:0
  • 审  稿 费:
    稿费:
  • 本刊可发:0
  • 特殊属性:英语

  • 联系方式

  • 投稿网址:https://manuscripts.jamaonc.com/
  • 官网网址:
  • 电话传真:
  • 电子邮箱:
  • 微信公众号:

审稿时间:暂无参考数据,审稿时间不确定!

投稿难度:网友分享,仅供参考

见刊周期:-

温馨提示以上只是参考信息,实际情况会根据投稿主题、稿件质量和数量、审稿流程有所差异。想获得更准确信息请联系期刊的编辑部进行咨询。

欢迎点评!让信息更透明,使投稿更轻松!
    • 审稿时间:
      是否录用:
    • 发表排期:
      查重要求:
    • 有无课题:
      有无回复:
    • 我的学历:
      我的职称:
    • 审稿费用:
      版面费用:
    • 稿       费:
      稿件字数:
    • 投稿难度:
    • 该刊可发:
    • 投稿主题:
匿名: 验证码: 点击切换验证码

    • 1、投稿方式:在线投稿。

      2、期刊网址:

      https://jamanetwork.com/journals/jamaoncology

      3、投稿网址:https://manuscripts.jamaonc.com/

      4、官网邮箱:jamaonc@jamanetwork.org

      5、期刊刊期:月刊,一年出版12期。

      202182日星期一

                                       

       

      投稿须知【官网信息】

       

      For Authors

      About JAMA Oncology

      JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

      Journal Frequency and Access. JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives over 2.1 million online visits annually and more than 2.9 million article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.

      Editorial Information. The journal’s acceptance rate is 12%. The median time to first decision is 2 days, and 39 days with review. The journal's Impact Factor is 31.8, one of the highest ranking among oncology journals. All articles are published online first. Additional information on the types of articles published and editorial policies is available in the journal's Instructions for Authors.

      Editorial Team. The founding Editor in Chief of JAMA Oncology is Mary L. (Nora) Disis, MD. Dr Disis is director of the UW Institute of Translational Health Science and the Center for Translational Medicine in Women's Health. She is also associate dean of the UW School of Medicine, dean of Research and Graduate Education, associate dean of Translational Science, Helen B. Slonaker Endowed Professor for Cancer Research, professor of Medicine and Oncology, and adjunct professor of Obstetrics & Gynecology and Pathology. For a complete listing of the journal's Editors and Editorial Board, see Editors and Publishers.

      Mission Statement. JAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

      JAMA Oncology

      ISSN 2374-2437 (Print)

      ISSN 2374-2445 (Online)

      Why Publish in JAMA Oncology?

      JAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer.

      Impact and Reach

      Impact Factor of 31.8, one of the highest ranking among oncology journals

      Over 2.1 million annual visits to the JAMA Oncology website; more than 2.9 million article views and downloads

      International authors: 51% of submissions come from outside the United States

      Extensive press coverage, with over 10,000 media mentions in 2020 and 2021 in outlets such as The Wall Street Journal, CNN, Forbes, and Reuters

      Top Altmetric scores—JAMA Oncology published 18 of the top 50 articles among oncology journals

      Number of citations, Altmetric score, page views, and PDF downloads tracked for your published article

      Broad reach through related commentary, author audio interviews, podcasts, email alerts, social media, multimedia, and more than 63,000 followers on Twitter and Facebook

      Prompt Decisions and Rapid Publication Timelines

      Highly selective peer review and editorial evaluation, with 12% acceptance rate for all submissions

      Median time to first decision: 2 days without external peer review; 39 days with review

      Online First publication of all major articles

      Author Service

      User-friendly manuscript submission system and process

      Prompt, expert review and consideration from our experienced editors

      Highest standards followed to improve your accepted manuscript’s accuracy, reliability, and readability

      CME credit available for lead authors who publish in JAMA Oncology

      Opportunity for your work to be augmented with expert illustration, interactive features, video, audio, and visual abstract

      Free public access: All research articles are free 12 months after publication on the journal's website

      Open access: Authors of research articles may elect to pay for immediate open access on the day of publication

      Direct deposit to PubMed Central: All research articles deposited directly in PubMed Central (PMC) for authors

      Online extras: Ability to post supplemental content online and download your article’s tables and figures as PowerPoint slides

      The JAMA Network advantage: Authors of papers not accepted by JAMA Oncology may have the option to have their papers and reviewers' comments automatically referred to one of the JAMA Network specialty journals and/or JAMA Network Open

      Dedicated media team to promote your article to the news media and on social media

      JAMA Network journals welcome manuscript submissions on diversity, equity, and inclusion. For example, see the Health Disparities Topic Collection and the list of articles on race, racism, and racial/ethnic disparities/inequities published during the last 5 years here.

      For more information, see JAMA Oncology Instructions for Authors. Submit your manuscript at https://manuscripts.jamaonc.com.

      Updated July 2021

      Contact Information

      JAMA Oncology, Mary L. (Nora) Disis, MD, Editor, Cancer Vaccine Institute, University of Washington, 850 Republican St, Box 358050, Seattle, WA 98109-4714; email: jamaonc@jamanetwork.org. Manuscripts should be submitted online at http://manuscripts.jamaonc.com.

      How Do I?

      Determine My Article Type

      Categories of Articles

      ……

      更多详情:

      https://jamanetwork.com/journals/jamaoncology/pages/for-authors




    验证码: 点击切换验证码